Erythromycin C

Erythromycin C is a lipid of Polyketides (PK) class.

Cross Reference

There are no associated biomedical information in the current reference collection.

Current reference collection contains 35291 references associated with Erythromycin C in LipidPedia. Due to lack of full text of references or no associated biomedical terms are recognized in our current text-mining method, we cannot extract any biomedical terms related to diseases, pathways, locations, functions, genes, lipids, and animal models from the associated reference collection.

Users can download the reference list at the bottom of this page and read the reference manually to find out biomedical information.

All references with Erythromycin C

Download all related citations
Per page 10 20 50 100 | Total 7634
Authors Title Published Journal PubMed Link
Draisci R et al. Confirmatory method for macrolide residues in bovine tissues by micro-liquid chromatography-tandem mass spectrometry. 2001 J Chromatogr A pmid:11554423
Gaisser S et al. New erythromycin derivatives from Saccharopolyspora erythraea using sugar O-methyltransferases from the spinosyn biosynthetic gene cluster. 2001 Mol. Microbiol. pmid:11555300
Suzuki T et al. Erythromycin and common cold in COPD. 2001 Chest pmid:11555501
Edelstein PH et al. In vitro activity of ABT-773 against Legionella pneumophila, its pharmacokinetics in guinea pigs, and its use to treat guinea pigs with L. pneumophila pneumonia. 2001 Antimicrob. Agents Chemother. pmid:11557455
Barry AL et al. In vitro activity of the ketolide ABT-773. 2001 Antimicrob. Agents Chemother. pmid:11557491
Yu KS et al. Ethnic differences and relationships in the oral pharmacokinetics of nifedipine and erythromycin. 2001 Clin. Pharmacol. Ther. pmid:11557910
Nishimoto A et al. Studies on macrolide antibiotics I. Synthesis and antibacterial activity of erythromycin A 9-O-substituted oxime ether derivatives against Mycobacterium avium complex. 2001 Chem. Pharm. Bull. pmid:11558597
Wu YJ and Su WG Recent developments on ketolides and macrolides. 2001 Curr. Med. Chem. pmid:11562291
Mahon BE et al. Maternal and infant use of erythromycin and other macrolide antibiotics as risk factors for infantile hypertrophic pyloric stenosis. 2001 J. Pediatr. pmid:11562617
Merits I The metabolism of labelled hexadecyl sulphate salts in the rat, dog and human. 1975 Biochem. J. pmid:1156404
Douthwaite S and Champney WS Structures of ketolides and macrolides determine their mode of interaction with the ribosomal target site. 2001 J. Antimicrob. Chemother. pmid:11566971
Afset JE and Maeland JA [Erythromycin and ciprofloxacin resistant Campylobacter jejuni]. 2001 Tidsskr. Nor. Laegeforen. pmid:11571989
Zatman TF et al. Gastric residual volume in children: a study comparing efficiency of erythromycin and metoclopramide as prokinetic agents. 2001 Br J Anaesth pmid:11573597
Pechère JC Macrolide resistance mechanisms in Gram-positive cocci. 2001 Int. J. Antimicrob. Agents pmid:11574191
Rubinstein E Comparative safety of the different macrolides. 2001 Int. J. Antimicrob. Agents pmid:11574199
MÃ¥rdh PA Human respiratory tract infections with mycoplasmas and their in vitro susceptibility to tetracyclines and some other antibiotics. 1975 Chemotherapy pmid:1157581
Farrow KA et al. Genomic analysis of the erythromycin resistance element Tn5398 from Clostridium difficile. 2001 Microbiology (Reading, Engl.) pmid:11577151
Korycka-Machala M et al. Polycations increase the permeability of Mycobacterium vaccae cell envelopes to hydrophobic compounds. 2001 Microbiology (Reading, Engl.) pmid:11577156
Spurlock G et al. Erythromycin binding studies on two different classes of antibiotic resistant mutant in Paramecium. 1975 FEBS Lett. pmid:1157936
Aracil B et al. High prevalence of erythromycin-resistant and clindamycin-susceptible (M phenotype) viridans group streptococci from pharyngeal samples: a reservoir of mef genes in commensal bacteria. 2001 J. Antimicrob. Chemother. pmid:11581247
Ramaswamy K and Jacobson K Infectious diarrhea in children. 2001 Gastroenterol. Clin. North Am. pmid:11586548
Tenson T and Mankin AS Short peptides conferring resistance to macrolide antibiotics. 2001 Peptides pmid:11587794
Boivin MA and Levy H Gastric feeding with erythromycin is equivalent to transpyloric feeding in the critically ill. 2001 Crit. Care Med. pmid:11588451
Altindis M et al. Turkish primary school students as carriers of group A beta-hemolytic streptococci and susceptibility of strains to penicillin and erythromycin. 2001 J Chemother pmid:11589490
Stary A European guideline for the management of chlamydial infection. 2001 Int J STD AIDS pmid:11589794
Kashimura M et al. Synthesis and antibacterial activity of the tricyclic ketolides TE-802 and its analogs. 2001 J. Antibiot. pmid:11592503
Okazaki N et al. Characteristics of macrolide-resistant Mycoplasma pneumoniae strains isolated from patients and induced with erythromycin in vitro. 2001 Microbiol. Immunol. pmid:11592636
Buitendijk SE Antibiotics in preterm labour. 2001 Lancet pmid:11597708
Singer JI and DeVoe WM Severe Mycoplasma pneumoniae infection in otherwise healthy siblings. 1979 J. Pediatr. pmid:115983
Cave VG The management of the several stages of syphilis. 1975 J Natl Med Assoc pmid:1159858
Hsueh PR et al. High incidence of erythromycin resistance among clinical isolates of Streptococcus agalactiae in Taiwan. 2001 Antimicrob. Agents Chemother. pmid:11600380
Nagai K et al. Activities of a new fluoroketolide, HMR 3787, and its (des)-fluor derivative RU 64399 compared to those of telithromycin, erythromycin A, azithromycin, clarithromycin, and clindamycin against macrolide-susceptible or -resistant Streptococcus pneumoniae and S. pyogenes. 2001 Antimicrob. Agents Chemother. pmid:11600391
Okamoto H et al. In vivo efficacy of telithromycin (HMR3647) against Streptococcus pneumoniae and Haemophilus influenzae. 2001 Antimicrob. Agents Chemother. pmid:11600393
Haas CE et al. Effects of metronidazole on hepatic CYP3A4 activity. 2001 Pharmacotherapy pmid:11601665
Nishino T An electron microscopic study of antagonism between cephalexin and erythromycin in Staphylococcus aureus. 1975 Jpn. J. Microbiol. pmid:1160202
Bolton WK et al. Ventriculojugular shunt nephritis with Corynebacterium bovis. Successful therapy with antibiotics. 1975 Am. J. Med. pmid:1163549
Boek-Dohalská L et al. alpha-Naphthoflavone acts as activator and reversible or irreversible inhibitor of rabbit microsomal CYP3A6. 2001 Chem. Biol. Interact. pmid:11640917
Costalos C et al. The effect of low-dose erythromycin on whole gastrointestinal transit time of preterm infants. 2001 Early Hum. Dev. pmid:11641030
Marchandin H et al. Distribution of macrolide resistance genes erm(B) and mef(A) among 160 penicillin-intermediate clinical isolates of Streptococcus pneumoniae isolated in southern France. 2001 Pathol. Biol. pmid:11642013
Maugein J et al. [In vitro activity of pristinamycin against Streptococcus pneumoniae]. 2001 Pathol. Biol. pmid:11642023
Chuma T et al. Antimicrobial susceptibilities of Campylobacter strains isolated from broilers in the southern part of Japan from 1995 to 1999. 2001 J. Vet. Med. Sci. pmid:11642273
Dans PE Treatment of Gonorrhea and syphilis: Part II--syphilis. 1975 South. Med. J. pmid:1166341
Faas H et al. Pressure-geometry relationship in the antroduodenal region in humans. 2001 Am. J. Physiol. Gastrointest. Liver Physiol. pmid:11668030
Rasmussen JE Toxic epidermal necrolysis. A review of 75 cases in children. 1975 Arch Dermatol pmid:1167045
Chiou WL et al. Use of the erythromycin breath test for in vivo assessments of cytochrome P4503A activity and dosage individualization. 2001 Clin. Pharmacol. Ther. pmid:11673745
Rivory LP and Watkins PB Erythromycin breath test. 2001 Clin. Pharmacol. Ther. pmid:11673756
Pantosti A et al. Activity of quinupristin-dalfopristin in invasive isolates of Streptococcus pneumoniae from Italy. 2001 Clin. Microbiol. Infect. pmid:11678935
Ohwada S et al. Low-dose erythromycin reduces delayed gastric emptying and improves gastric motility after Billroth I pylorus-preserving pancreaticoduodenectomy. 2001 Ann. Surg. pmid:11685031
Dubois J and St-Pierre C In vitro susceptibility study of BMS-284756 against Legionella species. 2001 Sep-Oct Diagn. Microbiol. Infect. Dis. pmid:11687318
Carreras C et al. Saccharopolyspora erythraea-catalyzed bioconversion of 6-deoxyerythronolide B analogs for production of novel erythromycins. 2002 J. Biotechnol. pmid:11689246
Niwa H et al. Rapid detection of mutations associated with resistance to erythromycin in Campylobacter jejuni/coli by PCR and line probe assay. 2001 Int. J. Antimicrob. Agents pmid:11691569
Gorrini M et al. Inhibition of human neutrophil elastase by erythromycin and flurythromycin, two macrolide antibiotics. 2001 Am. J. Respir. Cell Mol. Biol. pmid:11694455
Manning SD et al. Frequency of antibiotic resistance among group B Streptococcus isolated from healthy college students. 2001 Clin. Infect. Dis. pmid:11698992
Lobene RR Clinical studies of plaque control agents: an overview. 1979 J. Dent. Res. pmid:117032
Gonorrhea: recommended treatment schedules-1974. Part II: Disseminated gonococcal infection and gonococcal infection in pediatric patients. 1975 Obstet Gynecol pmid:1170528
Koh TW Risk of torsades de pointes from oral erythromycin with concomitant carbimazole (methimazole) administration. 2001 Pacing Clin Electrophysiol pmid:11707056
Snow JC et al. Corneal injuries during general anesthesia. 1975 Jul-Aug Anesth. Analg. pmid:1170781
Bührer C et al. Role of erythromycin for treatment of incipient chronic lung disease in preterm infants colonised with Ureaplasma urealyticum. 2001 Drugs pmid:11708762
Tanikawa T et al. Synthesis and antibacterial activity of acylides (3-O-acyl-erythromycin derivatives): a novel class of macrolide antibiotics. 2001 J. Med. Chem. pmid:11708904
Ma Z et al. Novel erythromycin derivatives with aryl groups tethered to the C-6 position are potent protein synthesis inhibitors and active against multidrug-resistant respiratory pathogens. 2001 J. Med. Chem. pmid:11708916
Teng LJ et al. High prevalence of inducible erythromycin resistance among Streptococcus bovis isolates in Taiwan. 2001 Antimicrob. Agents Chemother. pmid:11709309
de Azavedo JC et al. Prevalence and mechanisms of macrolide resistance in invasive and noninvasive group B streptococcus isolates from Ontario, Canada. 2001 Antimicrob. Agents Chemother. pmid:11709331
Neuhauser MM et al. Postantibiotic effects of ABT-773 and amoxicillin-clavulanate against Streptococcus pneumoniae and Haemophilus influenzae. 2001 Antimicrob. Agents Chemother. pmid:11709352
Singh KV et al. In vitro activities of a new ketolide, ABT-773, against multidrug-resistant gram-positive cocci. 2001 Antimicrob. Agents Chemother. pmid:11709359
Schmidt LE et al. Early postoperative erythromycin breath test correlates with hepatic cytochrome P4503A activity in liver transplant recipients. 2001 Clin. Pharmacol. Ther. pmid:11719731
Goldschmidt N et al. Compound cardiac toxicity of oral erythromycin and verapamil. 2001 Ann Pharmacother pmid:11724091
Maniatis AN et al. Dissemination of clonally unrelated erythromycin- and glycopeptide-resistant Enterococcus faecium isolates in a tertiary Greek hospital. 2001 J. Clin. Microbiol. pmid:11724887
Asai T et al. Pre-operative oral erythromycin reduces residual gastric volume and acidity. 2000 Br J Anaesth pmid:11732520
Kunin CM Letter: Erythromycin in staphylococcal infections. 1975 JAMA pmid:1173378
Espinosa de los Monteros LE et al. Outbreak of scarlet fever caused by an erythromycin-resistant Streptococcus pyogenes emm22 genotype strain in a day-care center. 2001 Pediatr. Infect. Dis. J. pmid:11734748
Syrogiannopoulos GA et al. High prevalence of erythromycin resistance of Streptococcus pyogenes in Greek children. 2001 Pediatr. Infect. Dis. J. pmid:11734765
Nogami K et al. Intravenous low-dose erythromycin administration for infants with feeding intolerance. 2001 Pediatr Int pmid:11737737
Johnson CN et al. In vitro activity of ABT-773, telithromycin and eight other antimicrobials against erythromycin-resistant Streptococcus pneumoniae respiratory isolates of children. 2001 Int. J. Antimicrob. Agents pmid:11738340
Hayney MS et al. Effect of influenza immunization on CYP3A4 activity. 2001 Vaccine pmid:11738750
Lebel MH and Mehra S Efficacy and safety of clarithromycin versus erythromycin for the treatment of pertussis: a prospective, randomized, single blind trial. 2001 Pediatr. Infect. Dis. J. pmid:11740322
Ho PL et al. Fluoroquinolone resistance among Streptococcus pneumoniae in Hong Kong linked to the Spanish 23F clone. 2001 Sep-Oct Emerging Infect. Dis. pmid:11747711
Honma Y et al. Enhanced anti-Shigella activity of erythromycin supplemented with sulfadiazine. 2001 FEMS Immunol. Med. Microbiol. pmid:11750221
Benedetti E et al. Treatment of severe pneumonia in kidney transplant recipients. 2001 Nov-Dec Transplant. Proc. pmid:11750552
von Eiff C and Peters G Comparative in vitro activity of ABT-773 and two macrolides against staphylococci. 2002 J. Antimicrob. Chemother. pmid:11751787
Kaul A Erythromycin as a prokinetic agent. 2002 J. Pediatr. Gastroenterol. Nutr. pmid:11753157
Jadcherla SR and Berseth CL Effect of erythromycin on gastroduodenal contractile activity in developing neonates. 2002 J. Pediatr. Gastroenterol. Nutr. pmid:11753158
Costalos C et al. Erythromycin as a prokinetic agent in preterm infants. 2002 J. Pediatr. Gastroenterol. Nutr. pmid:11753159
Sasaki M et al. Erythromycin and clarithromycin modulation of growth factor-induced expression of heparanase mRNA on human lung cancer cells in vitro. 2001 Mediators Inflamm. pmid:11759110
Gür D et al. Streptococcus pneumoniae penicillin resistance in Turkey. 2001 J Chemother pmid:11760219
Aziz EE et al. Risk factors for the development of Clostridium difficile toxin-associated diarrhoea: a pilot study. 2001 Jun-Jul Pharmacoepidemiol Drug Saf pmid:11760491
Coventry DR and Dilworth MJ Inhibition of protein synthesis by D-threo-chloramphenicol in the laboratory and nodule forms of Rhizobium lupini. 1975 J. Gen. Microbiol. pmid:1176963
García-Rey C et al. Importance of local variations in antibiotic consumption and geographical differences of erythromycin and penicillin resistance in Streptococcus pneumoniae. 2002 J. Clin. Microbiol. pmid:11773111
Richter SS et al. The molecular epidemiology of penicillin-resistant Streptococcus pneumoniae in the United States, 1994-2000. 2002 Clin. Infect. Dis. pmid:11774080
Coyle MB et al. Erythromycin and clindamycin resistance in Corynebacterium diphtheriae from skin lesions. 1979 Antimicrob. Agents Chemother. pmid:117748
Matsuura B et al. Differential determinants for peptide and non-peptidyl ligand binding to the motilin receptor. Critical role of second extracellular loop for peptide binding and action. 2002 J. Biol. Chem. pmid:11781320
Gan G et al. Intestinal absorption and presystemic elimination of the prokinetic agent, EM574, in the rabbit. 2002 J Pharm Sci pmid:11782911
Hertweck M et al. Inhibition of nuclear pre-mRNA splicing by antibiotics in vitro. 2002 Eur. J. Biochem. pmid:11784311
Shibuya Y et al. The effect of erythromycin on mucociliary transportability and rheology of cystic fibrosis and bronchiectasis sputum. 2001 Respiration pmid:11786718
Fuchs PC et al. Selection of zone size interpretive criteria for disk diffusion susceptibility tests of three antibiotics against Streptococcus pneumoniae, using the New Guidelines of the National Committee for Clinical Laboratory Standards. 2002 Antimicrob. Agents Chemother. pmid:11796348
Nagai K et al. Susceptibility to telithromycin in 1,011 Streptococcus pyogenes isolates from 10 central and Eastern European countries. 2002 Antimicrob. Agents Chemother. pmid:11796375
Guerin JM and Leibinger F Why not to use erythromycin in GI motility. 2002 Chest pmid:11796472
Tateda K et al. Potential of macrolide antibiotics to inhibit protein synthesis of Pseudomonas aeruginosa: suppression of virulence factors and stress response. 2000 J. Infect. Chemother. pmid:11810524
Mitsuya Y et al. Influence of macrolides on guanosine diphospho-D-mannose dehydrogenase activity in Pseudomonas biofilm. 2000 J. Infect. Chemother. pmid:11810531
Li M et al. In-vitro and in-vivo antibiotic susceptibilities of Lyme disease Borrelia isolated in China. 2000 J. Infect. Chemother. pmid:11810535
Lee K et al. Trends in serotypes and antimicrobial susceptibility of group B streptococci isolated in Korea. 2000 J. Infect. Chemother. pmid:11810542

Table of Content